Predictors of Significant Disease Activity Score-28 (Using C-reactive protein) Remission Achieved with Intravenous Golimumab in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy: Results of the Phase 3, Multicenter, Double-Blind, Placebo-Controlled Trial

被引：0
|
作者：
Bingham, Clifton O., III [1 ]
Weinblatt, Michael [2 ]
Mendelsohn, Alan [3 ]
Kim, Lilianne [3 ]
Mack, Michael [3 ]
Lu, Jiandong [3 ]
Baker, Daniel [3 ]
Westhovens, Rene [4 ]
机构：
[1] Johns Hopkins Univ, Baltimore, MD USA
[2] Brigham & Womens Hosp, Boston, MA 02115 USA
[3] Janssen Res & Dev LLC, Spring House, PA USA
[4] Univ Hosp KU Leuven, Louvain, Belgium
来源：
ARTHRITIS AND RHEUMATISM | 2012年 / 64卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1301
引用
收藏
页码：S558 / S558
页数：1
相关论文
共 50 条
  • [31] WITHDRAWAL OF ADALIMUMAB IN EARLY RHEUMATOID ARTHRITIS PATIENTS WHO ATTAINED STABLE LOW DISEASE ACTIVITY WITH ADALIMUMAB PLUS METHOTREXATE: RESULTS OF A PHASE 4, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    Kavanaugh, Arthur
    Emery, Paul
    Fleischmann, Roy
    van Vollenhoven, Ronald
    Pavelka, Karel
    Durez, Patrick
    Guerette, Benoit
    Santra, Sourav
    Redden, Laura
    Kupper, Hartmut
    Smolen, Josef S.
    RHEUMATOLOGY, 2012, 51 : 29 - 30
  • [32] Withdrawal of Adalimumab in Early Rheumatoid Arthritis Patients Who Attained Stable Low Disease Activity with Adalimumab Plus Methotrexate: Results of a Phase 4, Double-Blind, Placebo-Controlled Trial
    Kavanaugh, Arthur
    Emery, P.
    Fleischmann, Roy
    van Vollenhoven, Ronald F.
    Pavelka, Karel
    Durez, Patrick
    Guerette, Benoit
    Santra, Sourav
    Redden, Laura
    Kupper, Hartmut
    Peterson, Theresa
    Smolen, Josef
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S665 - S666
  • [33] Once-weekly administration of 50 mg etanercept in patients with active rheumatoid arthritis - Results of a multicenter, randomized, double-blind, placebo-controlled trial
    Keystone, EC
    Schiff, MH
    Kremer, JM
    Kafka, S
    Lovy, M
    DeVries, T
    Burge, DJ
    ARTHRITIS AND RHEUMATISM, 2004, 50 (02): : 353 - 363
  • [34] Efficacy and Safety of Levilimab in Combination with Methotrexate in Patients with Active Rheumatoid Arthritis: 56-Week Results of Phase III Randomized Double-Blind Placebo-Controlled Trial SOLAR
    Mazurov, V. I.
    Nasonov, E. L.
    Lila, A. M.
    Korolev, M. A.
    Prystrom, A. M.
    Kundzer, E. V.
    Soroka, N. F.
    Kastanayan, A. A.
    Povarova, T. V.
    Plaksina, T. V.
    Antipova, O. V.
    Krechikova, D. G.
    Smakotina, S. A.
    Tciupa, O. A.
    Puntus, E. V.
    Raskina, T. A.
    Shilova, L. N.
    Kropotina, T. V.
    Nesmeyanova, O. B.
    Popova, T. A.
    Vinogradova, I. B.
    Dokukina, E. A.
    Plotnikova, A. V.
    Pukhtinskaia, P. S.
    Zinkina-Orikhan, A. V.
    Linkova, Yu. N.
    Eremeeva, A. V.
    Lutckii, A. A.
    DOKLADY BIOCHEMISTRY AND BIOPHYSICS, 2024, 518 (01) : 403 - 416
  • [35] Intravenous Golimumab Inhibits Radiographic Progression and Maintains Clinical Efficacy and Safety In Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy: 2-Year Results Of a Phase 3 Trial Of Intravenous Golimumab.
    Weinblatt, Michael E.
    Bingham, Clifton O., III
    Mendelsohn, Alan M.
    Kim, Lilianne
    Lo, Kim Hung
    Noonan, Lenore
    Baker, Daniel
    Westhovens, Rene
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S1183 - S1183
  • [36] Utility of Vectra-DA™ On Assessment of Rheumatoid Arthritis Disease Activity and Golimumab Response: Results of a Pilot Study From a Phase 3 Trial in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy.
    Lamberth, Sarah
    Cherkas, Yauheniya
    Brodmerkel, Carrie
    Curran, Mark
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S916 - S916
  • [37] A Phase 1, Randomized, Double-Blind, Placebo-Controlled Multiple-Dose Study of Intravenous Staphylococcal Protein A in Patients with Active Rheumatoid Arthritis On Methotrexate: Safety, Pharmacokinetics and Efficacy.
    Bernton, Edward
    Krantz, Eduard
    Gannon, William, Jr.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S363 - S363
  • [38] Early combination therapy with etanercept and methotrexate in JIA patients shortens the time to reach an inactive disease state and remission: results of a double-blind placebo-controlled trial
    Alexeeva, Ekaterina
    Horneff, Gerd
    Dvoryakovskaya, Tatyana
    Denisova, Rina
    Nikishina, Irina
    Zholobova, Elena
    Malievskiy, Viktor
    Santalova, Galina
    Stadler, Elena
    Balykova, Larisa
    Spivakovskiy, Yuriy
    Kriulin, Ivan
    Alshevskaya, Alina
    Moskalev, Andrey
    PEDIATRIC RHEUMATOLOGY, 2021, 19 (01)
  • [39] Early combination therapy with etanercept and methotrexate in JIA patients shortens the time to reach an inactive disease state and remission: results of a double-blind placebo-controlled trial
    Ekaterina Alexeeva
    Gerd Horneff
    Tatyana Dvoryakovskaya
    Rina Denisova
    Irina Nikishina
    Elena Zholobova
    Viktor Malievskiy
    Galina Santalova
    Elena Stadler
    Larisa Balykova
    Yuriy Spivakovskiy
    Ivan Kriulin
    Alina Alshevskaya
    Andrey Moskalev
    Pediatric Rheumatology, 19
  • [40] Vedolizumab Induction Therapy for Crohn's Disease: Results of Gemini II, a Randomized, Placebo-Controlled, Double-Blind, Multicenter Phase 3 Trial
    Sandborn, William
    Sands, Bruce
    Colombel, Jean-Frederic
    Feagan, Brian
    Hanauer, Stephen
    Rutgeerts, Paul
    Lukas, Milan
    Fedorak, Richard
    Lee, Scott
    Bressler, Brian
    Xu, Jing
    Sankoh, Serap
    Stephens, Kristin
    Parikh, Asit
    Fox, Irving
    Milch, Catherine
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S624 - S625
12345